Once-weekly treatment for osteoporosis

被引：3

作者：

Stone, M ^{[1
]}

机构：

[1] Univ Wales, Llandough Hosp, Coll Med, Acad Ctr,Bone Res Unit, Penarth CF64 2XX, S Glam, Wales

来源：

HOSPITAL MEDICINE | 2002年 / 63卷 / 04期

关键词：

D O I：

10.12968/hosp.2002.63.4.2043

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Daily oral bisphosphonates are a well-established treatment option for osteoporosis. However, many patients find the daily dosing regimen inconvenient. Once-weekly alendronate offers greater convenience to patients while providing equal efficacy.

引用

页码：230 / 232

页数：3

共 11 条

[1] Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial [J].

Black, DM ;

Thompson, DE ;

Bauer, DC ;

Ensrud, K ;

Musliner, T ;

Hochberg, MC ;

Nevitt, MC ;

Suryawanshi, S ;

Cummings, SR .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4118-4124

[2] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[3] Weekly administration of alendronate: Rationale and plan for clinical assessment [J].

Bone, HG ;

Adami, S ;

Rizzoli, R ;

Favus, M ;

Ross, PD ;

Santora, A ;

Prahalada, S ;

Daifotis, A ;

Orloff, J ;

Yates, J .

CLINICAL THERAPEUTICS, 2000, 22 (01) :15-28

[4] EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS [J].

LIBERMAN, UA ;

WEISS, SR ;

BROLL, J ;

MINNE, HW ;

QUAN, H ;

BELL, NH ;

RODRIGUEZPORTALES, J ;

DOWNS, RW ;

DEQUEKER, J ;

FAVUS, M ;

SEEMAN, E ;

RECKER, RR ;

CAPIZZI, T ;

SANTORA, AC ;

LOMBARDI, A ;

SHAH, RV ;

HIRSCH, LJ ;

KARPF, DB .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1437-1443

[5] Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass:: Results of the FOSIT study [J].

Pols, HAP ;

Felsenberg, D ;

Hanley, DA ;

Stepán, J ;

Muñoz-Torres, M ;

Wilkin, TJ ;

Qin-sheng, G ;

Galich, AM ;

Vandormael, K ;

Yates, AJ ;

Stych, B .

OSTEOPOROSIS INTERNATIONAL, 1999, 9 (05) :461-468

[6] Pharmacokinetics of alendronate [J].

Porras, AG ;

Holland, SD ;

Gertz, BJ .

CLINICAL PHARMACOKINETICS, 1999, 36 (05) :315-328

[7]

*ROY COLL PHYS, 1999, OST CLIN GUID PREV T

[8]

*ROY COLL PHYS BON, 2000, OST CLIN GUID PREV T

[9]

Schnitzer T, 2000, AGING CLIN EXP RES, V12, P1

[10]

TORGERSON D, 2001, PRIMARY CARE UK KEY

← 1 2 →